73 related articles for article (PubMed ID: 17071630)
21. Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.
Avrutsky MI; Troy CM
Front Pharmacol; 2021; 12():701301. PubMed ID: 34305609
[TBL] [Abstract][Full Text] [Related]
22. NCOA1 is a novel susceptibility gene for multiple myeloma in the Chinese population: A case-control study.
Peng M; Zhao G; Yang F; Cheng G; Huang J; Qin X; Liu Y; Wang Q; Li Y; Qin D
PLoS One; 2017; 12(3):e0173298. PubMed ID: 28264017
[TBL] [Abstract][Full Text] [Related]
23. Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation.
Shaw BE; Lee F; Krishnamurthy S; Byrne JL; Seedhouse C; Mayor NP; Maldonado-Torres H; Saudemont A; Marsh SG; Madrigal JA; Russell NH
Bone Marrow Transplant; 2015 Feb; 50(2):237-43. PubMed ID: 25347010
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
Hosnijeh FS; Lan Q; Rothman N; San Liu C; Cheng WL; Nieters A; Guldberg P; Tjønneland A; Campa D; Martino A; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Krogh V; Tumino R; Panico S; Masala G; Weiderpass E; Huerta Castaño JM; Ardanaz E; Sala N; Dorronsoro M; Quirós JR; Sánchez MJ; Melin B; Johansson AS; Malm J; Borgquist S; Peeters PH; Bueno-de-Mesquita HB; Wareham N; Khaw KT; Travis RC; Brennan P; Siddiq A; Riboli E; Vineis P; Vermeulen R
Blood; 2014 Jul; 124(4):530-5. PubMed ID: 24899624
[TBL] [Abstract][Full Text] [Related]
25. Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Mekkaw P; Annamaneni S; Digumarthi RR; Sinha S; Satti V
Tumour Biol; 2014 Sep; 35(9):8813-22. PubMed ID: 24879622
[TBL] [Abstract][Full Text] [Related]
26. Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma.
Li Q; Lan Q; Zhang Y; Bassig BA; Holford TR; Leaderer B; Boyle P; Zhu Y; Qin Q; Chanock S; Rothman N; Zheng T
Cancer Causes Control; 2013 Oct; 24(10):1875-84. PubMed ID: 23913011
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of the CASP8 gene promoter may not be associated with colorectal cancer in Han Chinese from southwest China.
Xiao MS; Chang L; Li WL; Du YS; Pan Y; Zhang DF; Wen Y; Luo J; Li XY; Yao YG
PLoS One; 2013; 8(7):e67577. PubMed ID: 23844036
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
Berndt SI; Skibola CF; Joseph V; Camp NJ; Nieters A; Wang Z; Cozen W; Monnereau A; Wang SS; Kelly RS; Lan Q; Teras LR; Chatterjee N; Chung CC; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Armstrong BK; Cocco P; Zhang Y; Severi G; Zeleniuch-Jacquotte A; Lawrence C; Burdette L; Yuenger J; Hutchinson A; Jacobs KB; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Wang AH; Smedby KE; Adami HO; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Jones B; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Holly EA; Smith MT; Jackson RD; Tinker LF; Benavente Y; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Rabe KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Lanasa MC; Spector LG; Leis JF; Cunningham JM; Weinberg JB; Morrison VA; Caporaso NE; Norman AD; Linet MS; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Masala G; Weiderpass E; Chirlaque MD; Vermeulen RC; Travis RC; Giles GG; Albanes D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Offit K; Zelenetz A; Klein RJ; Spinelli JJ; Bertrand KA; Laden F; Giovannucci E; Kraft P; Kricker A; Turner J; Vajdic CM; Ennas MG; Ferri GM; Miligi L; Liang L; Sampson J; Crouch S; Park JH; North KE; Cox A; Snowden JA; Wright J; Carracedo A; Lopez-Otin C; Bea S; Salaverria I; Martin-Garcia D; Campo E; Fraumeni JF; de Sanjose S; Hjalgrim H; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Nat Genet; 2013 Aug; 45(8):868-76. PubMed ID: 23770605
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.
Chen Y; Lan Q; Zheng T; Zhao N; Holford TR; Lerro C; Dai M; Huang H; Liang J; Ma S; Leaderer B; Boyle P; Chanock S; Rothman N; Zhang Y
Leuk Res; 2013 Sep; 37(9):1120-4. PubMed ID: 23768868
[TBL] [Abstract][Full Text] [Related]
30. Caspase functions in cell death and disease.
McIlwain DR; Berger T; Mak TW
Cold Spring Harb Perspect Biol; 2013 Apr; 5(4):a008656. PubMed ID: 23545416
[TBL] [Abstract][Full Text] [Related]
31. Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population.
Liu H; Jiang X; Zhang MW; Pan YF; Yu YX; Zhang SC; Ma XY; Li QL; Chen K
J Zhejiang Univ Sci B; 2013 Jan; 14(1):47-57. PubMed ID: 23303631
[TBL] [Abstract][Full Text] [Related]
32. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.
Guan X; Liu Z; Liu H; Yu H; Wang LE; Sturgis EM; Li G; Wei Q
FASEB J; 2013 Apr; 27(4):1404-12. PubMed ID: 23271051
[TBL] [Abstract][Full Text] [Related]
33. Role of the CASP-9 Ex5+32 G>A polymorphism in susceptibility to cancer: A meta-analysis.
Yan S; Li YZ; Zhu XW; Liu CL; Wang P; Liu YL
Exp Ther Med; 2013 Jan; 5(1):175-180. PubMed ID: 23251262
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors of Follicular Lymphoma.
Ma S
Expert Opin Med Diagn; 2012 Jul; 6(4):323-333. PubMed ID: 22754588
[TBL] [Abstract][Full Text] [Related]
35. A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility.
Xu W; Jiang S; Xu Y; Chen B; Li Y; Zong F; Zhao W; Wu J
PLoS One; 2012; 7(5):e37443. PubMed ID: 22616010
[TBL] [Abstract][Full Text] [Related]
36. Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.
Gu S; Wu Q; Zhao X; Wu W; Gao Z; Tan X; Qian J; Chen H; Xie Y; Jin L; Han B; Lu D
Cancer Sci; 2012 Aug; 103(8):1451-9. PubMed ID: 22568453
[TBL] [Abstract][Full Text] [Related]
37. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.
Lavender NA; Rogers EN; Yeyeodu S; Rudd J; Hu T; Zhang J; Brock GN; Kimbro KS; Moore JH; Hein DW; Kidd LC
BMC Med Genomics; 2012 Apr; 5():11. PubMed ID: 22546513
[TBL] [Abstract][Full Text] [Related]
38. Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma.
Zhang Z; Yu X; Guo Y; Song W; Yu D; Zhang X
Cancer Sci; 2012 Mar; 103(3):555-60. PubMed ID: 22136337
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors of Non-Hodgkin Lymphoma.
Zhang Y; Dai Y; Zheng T; Ma S
Expert Opin Med Diagn; 2011 Nov; 5(6):539-550. PubMed ID: 22059093
[TBL] [Abstract][Full Text] [Related]
40. Identification of predictive pathways for non-hodgkin lymphoma prognosis.
Han X; Li Y; Huang J; Zhang Y; Holford T; Lan Q; Rothman N; Zheng T; Kosorok MR; Ma S
Cancer Inform; 2010 Dec; 9():281-92. PubMed ID: 21245948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
